Member news

Atriva reaches a development milestone and receives an additional tranche of running seed financing to develop its influenza therapeutic to clinical stage

More at atriva-therapeutics.com…

MorphoSys Announces That Its Licensee Janssen Has Initiated Two Phase 3 Studies with TremfyaTM (Guselkumab) in Psoriatic Arthritis

More at morphosys.com…

FGK celebrates its 15th anniversary – Dedicated to clinical research since 2002

More at fgk-cro.com…

Indivumed and Helomics partner to unlock the power of cancer biospecimens for drug discovery and development

More at indivumed.com…

NOXXON issues second tranche of ODIRNANE bonds

More at noxxon.com…

AYOXXA launches LUNARIS Mouse 12-Plex Th17 Kit to elucidate Th17 cell biology

More at ayoxxa.com…

MGI and Curetis to Collaborate on NGS-based Infectious Disease Diagnostics

More at curetis.com…